Sheldon Fleishman
Foot & Ankle Surgery · Blue Springs, MONPI 1245234640
Payments from drug & device makers
Across 65 payments — averaging $59.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kerecis Limited$2K
- Treace Medical Concepts, Inc.$504
- Tenex Health Inc.$233
- Organogenesis Inc.$218
- AbbVie$217
- Nevro Corp.$193
- plus $912 from 14 others
What the payments were for
- Travel & lodging$1,49338%
- Food & beverage$2,38762%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kerecis Limited | 11 | $1,603 |
| Treace Medical Concepts, Inc. | 6 | $504 |
| Tenex Health Inc. | 2 | $233 |
| Organogenesis Inc. | 5 | $218 |
| AbbVie(2 entities) | 7 | $217 |
| Nevro Corp. | 5 | $193 |
| Smith+Nephew | 4 | $169 |
| Averitas Pharma Inc. | 3 | $167 |
| Stryker(2 entities) | 6 | $129 |
| Baudax Bio Inc. | 2 | $125 |
| KCI USA, Inc. | 1 | $86 |
| Next Science LLC | 2 | $46 |
| Integra Lifesciences Corporation | 2 | $35 |
| Convatec Inc. | 2 | $34 |
| Zimmer Biomet | 1 | $27 |
| Kowa Pharmaceuticals America, Inc. | 2 | $26 |
| Polynovo North America LLC | 1 | $25 |
| Amgen | 1 | $20 |
| Linvatec Corporation | 1 | $13 |
| Paratek Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 Marigen$4,505
- Kerecis Omega3 SurgiClose$2,533
- Kerecis Omega3 GraftGuide$512
- Lapiplasty System$378
- PuraPly$125
- Grafix PRIME$122
- Grafix CORE$122
- Grafix XC$122
- Grafix PL PRIME$122
- Stravix$122
- Qutenza$122
- ANJESO$114
How this compares
$3,879 in reported general payments places this provider in the 45th percentile of 163 foot & ankle surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 57 | $940 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 38 | $401 |
| Terbinafine Hcl | 22 | $386 |
| Silver Sulfadiazine | 30 | $208 |
| Diclofenac Sodium | 37 | $179 |
| Amitriptyline Hcl | 20 | $147 |
| Cephalexin | 15 | $107 |
| Prednisone | 17 | $57 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Blue Springs
- Jeremy McCormickSaint Louis$1.5M
- Jeffrey JohnsonSaint Louis$944K
- Timothy BadweyKansas City$427K
- Amar PatelLees Summit$272K
- Raymond AbdoSaint Louis$251K
- Vincent SollecitoSaint Louis$221K
- Anthony LombardoBridgeton$132K
- Jason AndersonKansas City$131K
- John HoltzmanSaint Louis$129K
- Jesse WolfeSaint Louis$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.